← Back to Search

Anxiety Skills Training for Anxiety

Phase 3
Recruiting
Led By Robyn L. Shepardson, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age >=18 years
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 4 weeks, 8 weeks, 12 weeks, post-assessment (16 weeks), follow-up assessment (28 weeks)
Awards & highlights

Study Summary

This trial is testing whether a brief anxiety treatment is more effective at reducing anxiety symptoms and impairment in Veterans compared to usual care.

Who is the study for?
This trial is for Veterans aged 18 or older who have been seen at Syracuse or Western New York VA primary care clinics in the last year and are experiencing significant anxiety symptoms. It's not open to those with severe communication barriers, cognitive impairments that prevent informed consent, certain mental health diagnoses like OCD or SMI, current intensive psychotherapy for anxiety/depression, recent changes in psychotropic medications, severe depression, or PTSD.Check my eligibility
What is being tested?
The study compares a brief behavioral treatment called Veterans Anxiety Skills Training (VAST), which includes up to six 30-minute sessions focused on cognitive-behavioral skills tailored for Veterans' needs against usual care. The effectiveness of VAST will be measured by looking at the severity of anxiety symptoms and functional impairment before and after treatment.See study design
What are the potential side effects?
Since VAST is a non-medication intervention focusing on teaching coping skills for anxiety management rather than using drugs, it may not have typical drug side effects. However, discussing emotional topics during therapy could temporarily increase distress.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 4 weeks, 8 weeks, 12 weeks, post-assessment (16 weeks), follow-up assessment (28 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 4 weeks, 8 weeks, 12 weeks, post-assessment (16 weeks), follow-up assessment (28 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Overall Anxiety Severity and Impairment Scale change
Secondary outcome measures
Depression Anxiety Stress Scale-21 change
Other outcome measures
Columbia-Suicide Severity Rating Scale change
Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form change
Sheehan Disability Scale change

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention conditionExperimental Treatment1 Intervention
Modular cognitive-behavioral anxiety intervention tailored to and personalized for Veterans
Group II: Control conditionActive Control1 Intervention
Usual care anxiety treatment

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,611 Previous Clinical Trials
3,305,106 Total Patients Enrolled
17 Trials studying Anxiety
1,908 Patients Enrolled for Anxiety
Robyn L. Shepardson, PhDPrincipal InvestigatorSyracuse VA Medical Center, Syracuse, NY
1 Previous Clinical Trials
35 Total Patients Enrolled
1 Trials studying Anxiety
35 Patients Enrolled for Anxiety

Media Library

Veterans Anxiety Skills Training Intervention Clinical Trial Eligibility Overview. Trial Name: NCT04829240 — Phase 3
Anxiety Research Study Groups: Intervention condition, Control condition
Anxiety Clinical Trial 2023: Veterans Anxiety Skills Training Intervention Highlights & Side Effects. Trial Name: NCT04829240 — Phase 3
Veterans Anxiety Skills Training Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04829240 — Phase 3

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has the Veterans Anxiety Skills Training Intervention been federally approved?

"There is some clinical data supporting the efficacy of Veterans Anxiety Skills Training Intervention, and it has received a safety rating of 3."

Answered by AI

How many test subjects are participating in this research?

"Yes, this study is still open for recruitment according to the information found on clinicaltrials.gov. This particular trial was first posted on 8/17/2021 and has since been updated on 6/17/2022. The team running the trial are looking for 178 participants that will be spread out across 2 sites."

Answered by AI

Are people still being accepted into this clinical trial?

"That is accurate, the online clinicaltrials.gov registry has this trial listed as currently recruiting participants. This particular study was posted on August 17th, 2021 with the most recent update being June 17th, 2022. A total of 178 patients need to be enrolled from 2 locations."

Answered by AI

Who else is applying?

What state do they live in?
New York
What portion of applicants met pre-screening criteria?
Met criteria
What site did they apply to?
Syracuse VA Medical Center, Syracuse, NY
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

Because I have wicked bad anxiety and I have been talking medicine for it but it's doesn't work.
PatientReceived 1 prior treatment
Recent research and studies
clinicaltrials.govStudy
Brief Anxiety Skills Training Intervention for Veterans in Primary Care
2021. "Brief Anxiety Skills Training Intervention for Veterans in Primary Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04829240.
All > Anxiety
~42 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top